Intervention group, % | Control group, % | P-value | |
---|---|---|---|
Diabetes | |||
Baseline prevalence (2009–2010) | 5.90 | 4.56 | <0.001a |
Final prevalence (2012–2013) | 5.50 | 4.19 | <0.001a |
Change in prevalence | −0.40 | −0.37 | 0.747 |
Hypertension | |||
Baseline prevalence (2009–2010) | 15.26 | 14.14 | 0.088 |
Final prevalence (2012–2013) | 15.71 | 14.44 | 0.053 |
Change in prevalence | +0.46 | +0.30 | 0.544 |
Atrial fibrillation | |||
Baseline prevalence (2009–2010) | 1.30 | 1.57 | 0.002a |
Final prevalence (2012–2013) | 1.40 | 1.73 | 0.001a |
Change in prevalence | +0.10 | +0.15 | 0.514 |
Chronic kidney disease | |||
Baseline prevalence (2009–2010) | 4.90 | 4.48 | 0.448 |
Final prevalence (2012–2013) | 4.30 | 4.10 | 0.636 |
Change in prevalence | −0.60 | −0.38 | 0.542 |
Coronary heart disease | |||
Baseline prevalence (2009–2010) | 3.30 | 3.22 | 0.510 |
Final prevalence (2012–2013) | 3.20 | 3.11 | 0.660 |
Change in prevalence | −0.10 | −0.10 | 0.639 |
↵a P<0.05.